Our results shown that LGS could significantly enhance the expression of p-GSK-3β protein and inhibit GSK-3β expression, while Wortmannin could partially reverse these effects of LGS (Figure 5F). This evidence concerns the gene GSK3B and Lennox-Gastaut syndrome.